Congenital Generalized Lipodystrophy, also known as berardinelli-seip congenital lipodystrophy, is related to lipodystrophy, congenital generalized, type 4 and lipodystrophy, congenital generalized, type 3, and has symptoms including myalgia An important gene associated with Congenital Generalized Lipodystrophy is AGPAT2 (1-Acylglycerol-3-Phosphate O-Acyltransferase 2), and among its related pathways/superpathways are Metabolism and IL-9 Signaling Pathways. The drugs Propoxycaine and Anesthetics have been mentioned in the context of this disorder. Affiliated tissues include skin and liver, and related phenotypes are hepatomegaly and lipodystrophy